尽管最近的收益不及预期，但机构投资者仍调整了 UnitedHealth 的股份，该股仍被评为“买入”。 Institutional investors tweak stakes in UnitedHealth despite recent earnings miss, stock still rated "Buy."

Mendel Capital和Boothbay基金管理等机构投资者调整了他们在联合保健集团的股份,这是一家大型保健公司,市场上限为380.66亿美元。 Institutional investors like Mendel Capital and Boothbay Fund Management have adjusted their stakes in UnitedHealth Group, a major health care company with a market cap of $380.66 billion. 联合保健通过四个部分运作:联合保健、 Optum Health、Optum Insight 和 Optum Rx。 UnitedHealth operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. 尽管最近收入低于估计数,但该公司股票的“Buy”共识评级为603.05美元,平均目标价为603.05美元。 Despite recent earnings falling short of estimates, the company's stock has a "Buy" consensus rating and an average target price of $603.05.